Changes in elemental concentrations in LNCaP cells are associated with a protective effect of neuropeptides on etoposide-induced apoptosis

Cell Biology International

Volumn 28, Issue 5, 2004, Pages 397-402

  Salido, M ^a,b   Vilches, J ^a   Roomans, G M ^b  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Bombesin; Calcitonin; Electron probe X ray microanalysis; Intracellular ions; Neuropeptides; Prostate carcinoma

Indexed keywords

ETOPOSIDE; NEUROPEPTIDE; POTASSIUM; SODIUM;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL VIABILITY; CONTROLLED STUDY; ELECTRON PROBE MICROANALYSIS; HUMAN; HUMAN CELL; MALE; MORPHOLOGY; PROSTATE ADENOCARCINOMA; PROTEIN FUNCTION;

APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; ELECTRON PROBE MICROANALYSIS; ETOPOSIDE; HUMANS; KINETICS; MALE; MICROSCOPY, ELECTRON, SCANNING; NEUROPEPTIDES; POTASSIUM; PROSTATIC NEOPLASMS; PROTECTIVE AGENTS; SODIUM;

EID: 2942544816     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2004.03.008     Document Type: Article

References (19)

1. Aprikian A.G., Han K., Guy L., Landry F., Begin L.R., Chevalier S. Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancer. Prostate Suppl. 8:1998;52-61
2. Chien J., Ren Y., Qing Wang Y., Bordelon W., Thompson E., Davis R., et al. Calcitonin is a prostate-epithelium-derived growth stimulator peptide. Mol Cell Endocrinol. 181:2001;69-79
3. Clegg N., Ferguson C., True L., Arnold H., Moorman A., Quinn J., et al. Molecular characterization of prostatic small cell carcinoma. Prostate. 55:2003;55-64
4. Cox M.E., Deeble P.D., Lakhnai S., Parsons S.J. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res. 59:1999;3821-3830
5. Dallaporta B., Hirsch T., Susin S.A., Zamzami N., Larochette N., Brenner C., et al. Potassium leakage during the apoptosis degradation phase. J Immunol. 160:1998;5605-5615
6. Fernández-Segura E., Cañizares F.J., Cubero M.A., Warley A., Campos A. Changes in elemental content during apoptotic cell death studied by electron probe X-ray microanalysis. Exp Cell Res. 253:1999;454-462
7. Fixemer T., Remberger K., Bonkhoff H. Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma. Prostate. 53:2002;118-123
8. Goodin J.L., Rutherford C.L. Identification of differentially expressed genes during cyclic adenosine monophosphate-induced neuroendocrine differentiation in the human prostatic adenocarcinoma cell line LNCaP. Mol Carcinog. 33:2002;88-98
9. Hansson J., Abrahamsson P.A. Neuroendocrine pathogenesis in adenocarcinoma of the prostate. Ann Oncol. 12:(Suppl 2):2001;145-152
10. Hoosein N.M. Neuroendocrine and immune mediators in prostate cancer progression. Front Biosci. 3:1998;1274-1279
11. Ismail H., Landry F., Aprikian A.G., Chevalier S. Androgen ablation promotes neuroendocrine cell differentiation in dog and human prostate. Prostate. 51:2002;117-125
12. Ito T., Yamamoto S., Ohno Y., Namiki K., Aizawa T., Akiyama A., et al. Up-regulation of neuroendocrine differentiation in prostate cancer after androgen deprivation therapy, degree and androgen independence. Oncol Rep. 8:2001;1221-1224
13. Lee L.F., Guan J., Qiu Y., Kung H.J. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Mol Cell Biol. 21:2001;8385-8397
14. Maeno E., Ishizaki Y., Kanaseki T., Hazama A., Okada Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci USA. 97:2000;9487-9492
15. Matsushima H., Goto T., Hosaka Y., Kitamura T., Kawabe K. Correlation between proliferation, apoptosis and angiogenesis in prostate carcinoma and their relation to androgen ablation. Cancer. 85:1999;1822-1827
16. Salido M., Vilches J., Lopez A. Neuropeptides bombesin and calcitonin induce resistance to etoposide induced apoptosis in prostate cancer cell lines. Histol Histopathol. 15:2000;729-738
17. Salido M., Vilches J., Lopez A., Roomans G.M. Neuropeptides bombesin and calcitonin inhibit apoptosis related elemental changes in prostate cancer cell lines. Cancer. 94:2002;368-377
18. Segawa N., Mori I., Utsunomiya H., Nakamura M., Nakamura Y., Shan L., et al. Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer. Pathol Int. 51:2001;452-459
19. Wilson E.M., Oh Y., Hwa V., Rosenfeld R.G. Interaction of IGF-binding protein-related protein 1 with a novel protein, neuroendocrine differentiation factor, results in neuroendocrine differentiation of prostate cancer cells. J Clin Endocrinol Metab. 86:2001;4504-4511